Literature DB >> 8246952

Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.

J C Stone1, M Colleton, D Bottorff.   

Abstract

The GTPase activity of p21ras is stimulated by GTPase-activating proteins (GAPs) such as p120GAP and the product of the neurofibromatosis 1 gene, which may negatively regulate p21 function. GAPs are also proposed effectors of ras. We have sought activating substitutions in c-H-ras in the region encoding the effector domain, on the rationale that such mutations would dissociate effector function from negative regulation by GAP. One such activating mutation, Pro-34-->Arg, encodes protein that is substantially bound to GTP in vivo. In vitro, this protein is not stimulated by GAPs, and its binding to p120GAP is grossly impaired. The results support the idea that the p21 structural requirements for effector function and GAP interaction are quite different and suggest that some molecule(s) other than p120GAP serves as the ras effector. In contrast to the results obtained with p120GAP, the Pro-34-->Arg p21 species is effectively coupled to the raf-1 product, as judged from electrophoretic mobility shifts of the Raf-1 phosphoprotein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246952      PMCID: PMC364802          DOI: 10.1128/mcb.13.12.7311-7320.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62.

Authors:  G Wong; O Müller; R Clark; L Conroy; M F Moran; P Polakis; F McCormick
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

2.  ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK.

Authors:  K W Wood; C Sarnecki; T M Roberts; J Blenis
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

3.  Mutational and kinetic analyses of the GTPase-activating protein (GAP)-p21 interaction: the C-terminal domain of GAP is not sufficient for full activity.

Authors:  P Gideon; J John; M Frech; A Lautwein; R Clark; J E Scheffler; A Wittinghofer
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

4.  Molecular cloning of cDNAs encoding the GAP-associated protein p190: implications for a signaling pathway from ras to the nucleus.

Authors:  J Settleman; V Narasimhan; L C Foster; R A Weinberg
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

5.  Genetic definition of ras effector elements.

Authors:  J C Stone; R A Blanchard
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

6.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.

Authors:  T N Basu; D H Gutmann; J A Fletcher; T W Glover; F S Collins; J Downward
Journal:  Nature       Date:  1992-04-23       Impact factor: 49.962

7.  Somatic mutations in the neurofibromatosis 1 gene in human tumors.

Authors:  Y Li; G Bollag; R Clark; J Stevens; L Conroy; D Fults; K Ward; E Friedman; W Samowitz; M Robertson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

8.  Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.

Authors:  J E DeClue; A G Papageorge; J A Fletcher; S R Diehl; N Ratner; W C Vass; D R Lowy
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

9.  The Drosophila roughened mutation: activation of a rap homolog disrupts eye development and interferes with cell determination.

Authors:  I K Hariharan; R W Carthew; G M Rubin
Journal:  Cell       Date:  1991-11-15       Impact factor: 41.582

10.  Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases.

Authors:  S M Thomas; M DeMarco; G D'Arcangelo; S Halegoua; J S Brugge
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

View more
  11 in total

1.  Hypothermic stress leads to activation of Ras-Erk signaling.

Authors:  E Y Chan; S L Stang; D A Bottorff; J C Stone
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles.

Authors:  P Morcos; N Thapar; N Tusneem; D Stacey; F Tamanoi
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

3.  Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.

Authors:  Martin Zenker; Katarina Lehmann; Anna Leana Schulz; Helmut Barth; Dagmar Hansmann; Rainer Koenig; Rudolf Korinthenberg; Martina Kreiss-Nachtsheim; Peter Meinecke; Susanne Morlot; Stefan Mundlos; Anne S Quante; Salmo Raskin; Dirk Schnabel; Lars-Erik Wehner; Christian P Kratz; Denise Horn; Kerstin Kutsche
Journal:  J Med Genet       Date:  2006-10-20       Impact factor: 6.318

4.  Transformation and pp60v-src autophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and kinase-active, transformation-defective alleles of v-src.

Authors:  M F Verderame; J L Guan; K M Woods Ignatoski
Journal:  Mol Biol Cell       Date:  1995-08       Impact factor: 4.138

5.  RAS signalling is abnormal in a c-raf1 MEK1 double mutant.

Authors:  D Bottorff; S Stang; S Agellon; J C Stone
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

6.  Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of rat2 cells.

Authors:  S Stang; D Bottorff; J C Stone
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

7.  Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.

Authors:  Lothar Gremer; Torsten Merbitz-Zahradnik; Radovan Dvorsky; Ion C Cirstea; Christian Peter Kratz; Martin Zenker; Alfred Wittinghofer; Mohammad Reza Ahmadian
Journal:  Hum Mutat       Date:  2010-12-09       Impact factor: 4.878

8.  Biochemical and functional characterization of germ line KRAS mutations.

Authors:  Suzanne Schubbert; Gideon Bollag; Natalya Lyubynska; Hoa Nguyen; Christian P Kratz; Martin Zenker; Charlotte M Niemeyer; Anders Molven; Kevin Shannon
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

9.  Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases.

Authors:  L Cohen; R Mohr; Y Y Chen; M Huang; R Kato; D Dorin; F Tamanoi; A Goga; D Afar; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 10.  An unexpected new role of mutant Ras: perturbation of human embryonic development.

Authors:  Christian P Kratz; Charlotte M Niemeyer; Martin Zenker
Journal:  J Mol Med (Berl)       Date:  2007-01-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.